Talk Bio

FDA Releases 14 New Drug Rejection Letters After 3‑Month Pause in Transparency Policy

FDA Publishes Complete Response Letters Revealing Manufacturing and Data Gaps as Primary Reasons for Drug Rejections

Unnamed Pharma Files Citizen Petition Urging FDA to Reform CRL Disclosure Practices

FDA Publishes New Filing Checklists to Prevent Drug Submission Delays